The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
-
Published:2020-01
Issue:1
Volume:97
Page:202-212
-
ISSN:0085-2538
-
Container-title:Kidney International
-
language:en
-
Short-container-title:Kidney International
Author:
van Bommel Erik J.M.ORCID,
Muskiet Marcel H.A.,
van Baar Michaël J.B.,
Tonneijck Lennart,
Smits Mark M.,
Emanuel Anna L.,
Bozovic Andrea,
Danser A.H. Jan,
Geurts Frank,
Hoorn Ewout J.,
Touw Daan J.,
Larsen Emil L.,
Poulsen Henrik E.,
Kramer Mark H.H.,
Nieuwdorp Max,
Joles Jaap A.,
van Raalte Daniël H.
Cited by
219 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献